What is a stock summary page? Click here for an overview.
Business Description
Valneva SE
ISIN : FR0004056851
Compare
Compare
Traded in other countries / regions
VLA.France0OB3.UKVALN.USAAYJ.GermanyVLA.AustriaAYJ.Bulgaria IPO Date
2011-01-19Description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.93 | |||||
| Debt-to-EBITDA | 9.51 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.56 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3 | |||||
| 3-Year EBITDA Growth Rate | 5.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2 | |||||
| 3-Year Book Growth Rate | 2.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 16.52 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.76 | |||||
| 9-Day RSI | 57.08 | |||||
| 14-Day RSI | 55.94 | |||||
| 3-1 Month Momentum % | 90.74 | |||||
| 6-1 Month Momentum % | 42.58 | |||||
| 12-1 Month Momentum % | 10.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.78 | |||||
| Quick Ratio | 2.25 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 178.24 | |||||
| Days Sales Outstanding | 80.19 | |||||
| Days Payable | 147.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.2 | |||||
| Shareholder Yield % | -8.33 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.58 | |||||
| Operating Margin % | -51.44 | |||||
| Net Margin % | -4.68 | |||||
| FCF Margin % | -106.39 | |||||
| ROE % | -4.32 | |||||
| ROA % | -1.5 | |||||
| ROIC % | -27.77 | |||||
| 3-Year ROIIC % | -99.49 | |||||
| ROC (Joel Greenblatt) % | 10.95 | |||||
| ROCE % | 6.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 165.11 | |||||
| PS Ratio | 3.08 | |||||
| PB Ratio | 2.53 | |||||
| Price-to-Tangible-Book | 2.97 | |||||
| EV-to-EBIT | 28.25 | |||||
| EV-to-EBITDA | 28.25 | |||||
| EV-to-Revenue | 3.77 | |||||
| EV-to-Forward-Revenue | 3.23 | |||||
| EV-to-FCF | -3.51 | |||||
| Price-to-GF-Value | 1.06 | |||||
| Price-to-Median-PS-Value | 1.12 | |||||
| Price-to-Net-Current-Asset-Value | 112.87 | |||||
| Earnings Yield (Greenblatt) % | 3.54 | |||||
| FCF Yield % | -30.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valneva SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 158.535 | ||
| EPS (TTM) (€) | -0.06 | ||
| Beta | 1.65 | ||
| 3-Year Sharpe Ratio | -0.58 | ||
| 3-Year Sortino Ratio | -0.77 | ||
| Volatility % | 66.63 | ||
| 14-Day RSI | 55.94 | ||
| 14-Day ATR (€) | 0.178367 | ||
| 20-Day SMA (€) | 3.3671 | ||
| 12-1 Month Momentum % | 10.52 | ||
| 52-Week Range (€) | 1.717 - 4.292 | ||
| Shares Outstanding (Mil) | 162.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valneva SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valneva SE Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valneva SE Frequently Asked Questions
What is Valneva SE(LTS:0OB3)'s stock price today?
The current price of LTS:0OB3 is €3.39. The 52 week high of LTS:0OB3 is €4.29 and 52 week low is €1.72.
When is next earnings date of Valneva SE(LTS:0OB3)?
The next earnings date of Valneva SE(LTS:0OB3) is 2025-05-07.
Does Valneva SE(LTS:0OB3) pay dividends? If so, how much?
Valneva SE(LTS:0OB3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers